On April 8, 2016, iCAD, Inc., (Nasdaq: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the identification and treatment of cancer, reported that its mammography Computer Aided Detection (CAD) solution is now available on Fujifilm’s Aspire Cristalle full field digital mammography system (Press release, Fujifilm, APR 8, 2016, View Source [SID:1234510617]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
"iCAD is pleased to provide our leading mammography CAD solution to Fujifilm’s Aspire Cristalle customers worldwide. We trust our integrated solutions will now provide radiologists with a clinical decision support tool designed to help provide the highest quality care for mammography patients", said Diane Clifford, director of marketing for cancer detection solutions at iCAD.
The PowerLook Advanced Mammography Platform is a flexible solution supporting iCAD’s industry leading computer-aided detection algorithm for digital mammography that assists radiologists in the detection of breast cancer. The iCAD solution is used by more than 3,000 mammography facilities worldwide.
"Fujifilm is happy to have reached this important milestone with iCAD, moving our customers another important step forward with the ability to simplify the reading of digital mammography exams" said Rob Fabrizio, director of marketing and product development at FUJIFILM Medical Systems U.S.A., Inc. "We trust our customers will be pleased with this coupling of the most requested CAD platform with the exceptional imaging capabilities of our Aspire Cristalle mammography system."
Fujifilm is constantly working to develop the most advanced digital mammography systems, to assist in the early detection of breast cancer. Aspire Cristalle brings together Fujifilm’s extensive research, expertise and experience. The unique platform allows easy upgradability to future technologies, while offering optimal imaging of all breast types at lower dose. The Aspire Cristalle will be on display at the National Consortium of Breast Centers (NCoBC) conference from April 9-13, 2016 in Las Vegas, NV.